NVS: Novartis AG

NVS haberleri

• Seeking Alpha 14:15 The Play On TG Therapeutics (NASDAQ:TGTX)
• Seeking Alpha 19:03 Merck Stock Is Almost A Classical Benjamin Graham Investment
• Zacks 15:45 INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales
• Seeking Alpha 13:15 Franklin Mutual International Value Fund Q2 2025 Commentary
• Seeking Alpha 00:45 Fidelity Overseas Fund Q2 2025 Commentary (Mutual Fund:FOSFX)
• Seeking Alpha 20:00 Franklin Mutual Global Discovery Fund Q2 2025 Commentary
• Seeking Alpha 11:55 Fidelity International Capital Appreciation Fund Q2 2025 Commentary (Mutual Fund:FIVFX)
• Benzinga 15:09 Sarepta Gets Thumbs Down From Regulators Regarding Gene Therapy - Sarepta Therapeutics (NASDAQ:SRPT)
• Investor's Business Daily 18:55 The Hits Keep Coming For Sarepta. Why Its Latest Setback Creates A 'Dangerous Precedent.'
• Zacks 15:42 Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
• Zacks 13:40 Here's Why Novartis (NVS) is a Strong Value Stock
• Zacks 12:50 Why Investors Need to Take Advantage of These 2 Medical Stocks Now
• Seeking Alpha 03:35 Dodge & Cox International Stock Fund Q2 2025 Shareholder Letter
• Benzinga 18:15 Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - AstraZeneca (NASDAQ:AZN)
• Zacks 15:43 AZN Commits USD50B to US Manufacturing Expansion Amid Tariff Pressures
• The Motley Fool 10:33 Highest Ever for This International Stock ETF -- But Analysts Say It Has Room to Run
• Zacks 10:20 Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
• Zacks 13:41 Betting Big on Cancer: 3 Oncology Stocks Set to Surge in 2025
• Seeking Alpha 06:54 Novartis AG 2025 Q2 - Results - Earnings Call Presentation (NYSE:NVS)
• Seeking Alpha 06:50 Novartis AG (NVS) Q2 2025 Earnings Call Transcript
• The Motley Fool 14:49 Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
• Zacks 14:22 Buy These 5 Low-Leverage Stocks Amid Impressive Retail Sales Data
• Seeking Alpha 15:32 Takeda: Positioned To Tackle Future Clinical Demand In A Highly Regulated Sector (TAK)
• Zacks 13:40 Novartis Beats on Q2 Earnings and Sales, CFO Retires, Stock Down